Tate & Lyle Accepts £2.7bn Ingredion Bid at 59% Premium
UL•Tate & Lyle has accepted a £2.7bn cash offer from Ingredion at 615p per share, reflecting a 59% premium over its May 13 closing price. The deal caps a share-price slump fueled by profit warnings and weak sweetener demand following last year’s £1.4bn CP Kelco acquisition.
1. Takeover Terms
Tate & Lyle’s board has unanimously recommended Ingredion’s cash offer totalling £2.7bn, equating to 595p per share plus dividends for a total of 615p per share. The bid represents a 59% premium over the company’s May 13 closing price and values the business at roughly £2.7bn.
2. Performance and Strategic Rationale
The takeover follows a prolonged decline in Tate & Lyle’s share price driven by a series of profit warnings and subdued demand for its Splenda sweetener. Last year’s £1.4bn acquisition of CP Kelco aimed to diversify into texture and mouthfeel ingredients but did not offset broader economic headwinds.
3. Future Outlook
Ingredion plans to leverage complementary portfolios to create a global leader in ingredient solutions and has signaled increased investment in innovation and scale. Both chairmen cited enhanced geographic reach and potential for growth as key drivers of the combined entity’s future performance.
